Aug 7 (Reuters)-
Stemcell Institute
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2024 Jun 30, 2023 Mar 31, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 678 mln 577 mln 3.00
(+17.6 pct) (+17.1 pct) (+20.9 pct)
Operating 123 mln 88 mln 600 mln
(+39.5 pct) (+20.1 pct) (+45.0 pct)
Recurring 124 mln 90 mln 600 mln
(+37.6 pct) (+22.1 pct) (+43.8 pct)
Net 178 mln 75 mln 500 mln
(+135.7 pct) (+49.6 pct) (+60.8 pct)
EPS 17.41 yen 7.39 yen 48.80 yen
Ann Div NIL 25.00 yen
-Q2 div NIL 25.00 yen
-Q4 div NIL NIL
NOTE - Stemcell Institute.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=7096.T